Physician profile
Chandra Kumar Krishna
NPI 1558701706
$457.75
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $64.57 · 2021: $92.00 · 2023: $33.50 · 2024: $71.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $220.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $68.19 | 2023-2024 | |
| Vifor Pharma, INC. | $53.93 | 2019 | |
| Allergan, INC. | $23.37 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $21.53 | 2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.39 | 2019 | |
| Abbvie INC. | $14.88 | 2023 | |
| Ekos Corporation | $14.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.89 | 2019 | |
| Medtronic Vascular, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.